Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Cell And Gene Therapy Clinical Trial Services Market Growth Analysis: How Will Revenue Expand During The Forecast Period?

The market for clinical trial services in cell and gene therapies has experienced substantial expansion recently, projecting a rise from $4.18 billion in 2025 to $4.62 billion in 2026, reflecting a compound annual growth rate of 10.3%. This upswing during the historical period is underpinned by a surge in cell and gene therapy clinical trials, a greater reliance on specialized contract research organizations (CROs), the increasing intricacy of trial protocols, an amplified focus on rare disease studies, and heightened regulatory scrutiny of cutting-edge therapeutic approaches.

The market for cell and gene therapy clinical trial services is projected for substantial expansion, anticipated to reach $6.44 billion by 2030, reflecting an 8.7% compound annual growth rate (CAGR). This upward trajectory over the forecast period stems from several key factors, including a heightened demand for late-stage clinical trial support, the escalating use of digital technologies in trials, broadened efforts in global patient recruitment, a greater emphasis on incorporating real-world evidence, and increased financial commitments towards precision clinical research. Dominant trends shaping this market include a growing embrace of decentralized clinical trial methodologies, the increasing utilization of digital platforms for patient recruitment, the seamless integration of sophisticated data management systems, the expansion of international trial site networks, and a more pronounced attention to regulatory adherence and trial precision.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15535&type=smp

#Cell And Gene Therapy Clinical Trial Services Market Growth Factors: Which Forces Are Supporting Market Expansion?

The increasing prevalence of genetic disorders is anticipated to be a significant catalyst for the expansion of the cell and gene therapy clinical trial services sector. These genetic conditions, stemming from alterations in an individual’s deoxyribonucleic acid or genetic makeup, are becoming more common due to several contributing elements such as enhanced accessibility to genetic screening, the natural occurrence of genetic mutations, and the continued practice of marriages between closely related individuals. Services within cell and gene therapy clinical trials are designed to combat this surge in genetic diseases by fostering the creation of innovative therapeutic strategies, enabling personalized treatment plans, expediting the transition of scientific discoveries into clinical applications, and broadening the therapeutic avenues for individuals affected by genetic conditions. As an illustration, the National Health Service in the United Kingdom reported in 2023 that sickle cell disorder holds the distinction of being the most prevalent inherited condition in England, affecting approximately 17,000 individuals (NHSE, 2023). Consequently, the escalating occurrence of genetic diseases is directly fueling the growth trajectory of the market for cell and gene therapy clinical trial services.

Cell And Gene Therapy Clinical Trial Services Market Segment Analysis And Revenue Opportunities

The cell and gene therapy clinical trial services market covered in this report is segmented –

1) By Service: Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Biostatics, Site Management And Monitoring, Other Services

2) By Therapy Type: Gene Therapy, Cell Therapy, Gene Modified Cell Therapy

3) By Indication: Oncology, Hematology, Metabolic Disorders, Infectious Diseases, Neurology, Cardiovascular Diseases, Musculoskeletal Disorders, Other Indications

4) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Clinical Trial Design And Planning: Protocol Development, Trial Feasibility Studies, Trial Design Consultation, Patient Recruitment And Enrollment Strategy, Risk-Based Monitoring Plans

2) By Supply And Logistic Services: Clinical Trial Supply Chain Management, Cold Chain Logistics, Packaging And Labeling Services, Transportation And Distribution Of Biological Samples, Customs And Import/Export Services

3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting, Regulatory Submission And Documentation, Compliance With GMP (Good Manufacturing Practices), Regulatory Pathway Consultation, Clinical Trial Applications (CTAs)

4) By Data Management And Biostatistics: Clinical Data Management (CDM), Statistical Analysis And Reporting, Clinical Data Monitoring, Data Integration And Validation, Electronic Data Capture (EDC) Solutions

5) By Site Management And Monitoring: Site Selection And Initiation, Clinical Monitoring And Site Visits, Patient Recruitment And Retention, Site Training And Support, Site Performance Monitoring

6) By Other Services: Patient Advocacy And Engagement, Real-World Evidence (RWE) Studies, Post-Trial Services, Medical Writing And Documentation, Clinical Trial Auditing And Inspection

Cell And Gene Therapy Clinical Trial Services Market Industry Trends: What Changes Are Reshaping Demand?

In the cell and gene therapy clinical trial services arena, leading entities are prioritizing the integration of cutting-edge technology, specifically customer relationship management (CRM) systems, to enhance operational effectiveness and secure market superiority. The CRM systems employed within cell and gene therapy clinical trial services are designed to optimize and synchronize all communications with trial participants, medical professionals, and other involved parties across the lifecycle of a clinical trial. Demonstrating this trend, AmerisourceBergen Corporation, a prominent healthcare firm based in the United States, introduced its Cell and Gene Therapy (CGT) Integration Hub in April 2023. This newly launched platform is engineered to foster greater interconnectedness and simplify workflows within the entire cell and gene therapy treatment continuum. Leveraging AmerisourceBergen’s established CRM infrastructure, the CGT Integration Hub endeavors to expedite the journey to care, partly by furnishing physicians and patient support teams with improved transparency concerning the development and administration phases of these advanced therapies. With functionalities encompassing accelerated benefits verification, live progress monitoring, and preemptive notifications, the CGT Integration Hub is geared towards simplifying the coordination of care, reducing obstacles, and ultimately elevating the overall experience for both patients and providers involved in the delivery of cell and gene therapies.

Cell And Gene Therapy Clinical Trial Services Market Leading Players Shaping Industry Direction

Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.

Access The Complete Cell And Gene Therapy Clinical Trial Services Market Report:

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-clinical-trial-services-global-market-report

Cell And Gene Therapy Clinical Trial Services Market Regional Outlook: Where Are The Largest Opportunities Located?

North Americawas the largest region in the cell and gene therapy clinical trial services market in 2025. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model